Trials / Completed
CompletedNCT02786992
Misoprostol+Oxytocin vs. Carbetocin in CS
Adjuvant Use of Misoprostol and Oxytocin vs. Carbetocin for the Prevention of Post-partum Hemorrhage in Elective Cesarian Section
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 600 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
This prospective randomized double-blind clinical trial will be conducted at Ain-Shams University Maternity Hospital, Cairo, Egypt. Patients eligible for elective lower segment cesarean section will be randomized to 2 groups. Group 1: will receive 400 ug misoprostol following + 10 IU oxytocin intravenous slowly after cord clamping. Group 2: will receive 100 ug carbetocin intravenous after cord clamping.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Misoprostol | |
| DRUG | Oxytocin | |
| DRUG | Carbetocin | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2020-01-01
- Completion
- 2020-01-01
- First posted
- 2016-06-01
- Last updated
- 2020-07-08
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02786992. Inclusion in this directory is not an endorsement.